Evidence map›Paper›PMID 40579240›Full record

ArticleBreast (Edinburgh, Scotland)2025

Corrigendum to "Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022" [The Breast 78 (2024) 103790].

A De Luca, M I Amabile, F Santori, S Di Matteo, M Tomatis, A Ponti, F Frusone, M Taffurelli, C Tinterri, L Marotti and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast (Edinburgh, Scotland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

A De LucaDepartment of Surgery, Sapienza University of Rome, Rome, Italy.
M I AmabileDepartment of Surgery, Sapienza University of Rome, Rome, Italy. Electronic address: mariaida.amabile@uniroma1.it.
F SantoriBreast Center, Azienda Ospedaliera San Giovanni-Addolorata, Rome, Italy; Surgical Residency Program, University of Tor Vergata, Rome, Italy.
S Di MatteoBreast Center, Azienda Ospedaliera San Giovanni-Addolorata, Rome, Italy; Surgical Residency Program, Federico II University, Naples, Italy.
M TomatisAOU Città della Salute e della Scienza, CPO Piemonte and SENONETWORK Data, Warehouse, Turin, Italy.
A PontiAOU Città della Salute e della Scienza, CPO Piemonte and SENONETWORK Data, Warehouse, Turin, Italy.
F FrusoneDepartment of Surgery, Sapienza University of Rome, Rome, Italy.
M TaffurelliIRCCS Policlinico S. Orsola Hospital, University of Bologna, Bologna, Italy.
C TinterriHumanitas Research Hospital and Cancer Center, Breast Surgery, Rozzano, Italy.
L MarottiEusoma, Florence, Italy.
M CalabreseDepartment of Radiology, IRCCS-Ospedale Policlinico San Martino, Genoa, Italy.
C MarchiòDepartment of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
F PuglisiDepartment of Medicine, University of Udine, Udine, Italy; Department of Medical Oncology, National Cancer Institute, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano, PN, Italy.
I PalumboRadiation Oncology Section, University of Perugia and Perugia General Hospital, Perugia, Italy.
L FortunatoBreast Center, Azienda Ospedaliera San Giovanni-Addolorata, Rome, Italy.
Senonet Collaborative Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40579240
PMCPMC12282482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.